1. Home
  2. KALA vs FENG Comparison

KALA vs FENG Comparison

Compare KALA & FENG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KALA BIO Inc.

KALA

KALA BIO Inc.

HOLD

Current Price

$0.70

Market Cap

17.4M

Sector

Health Care

ML Signal

HOLD

Logo Phoenix New Media Limited

FENG

Phoenix New Media Limited

HOLD

Current Price

$1.50

Market Cap

18.1M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
KALA
FENG
Founded
2009
1998
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Broadcasting
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
17.4M
18.1M
IPO Year
2017
2011

Fundamental Metrics

Financial Performance
Metric
KALA
FENG
Price
$0.70
$1.50
Analyst Decision
Buy
Analyst Count
3
0
Target Price
$31.50
N/A
AVG Volume (30 Days)
56.8K
2.8K
Earning Date
04-15-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
67.39
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.07
$1.39
52 Week High
$20.58
$3.65

Technical Indicators

Market Signals
Indicator
KALA
FENG
Relative Strength Index (RSI) 29.61 52.07
Support Level $0.56 $1.50
Resistance Level $0.72 $1.80
Average True Range (ATR) 0.12 0.04
MACD 0.01 0.00
Stochastic Oscillator 4.41 46.67

Price Performance

Historical Comparison
KALA
FENG

About KALA KALA BIO Inc.

Kala Bio Inc is a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of inventive therapies for rare and severe diseases of the front and back of the eye. It main product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.

About FENG Phoenix New Media Limited

Phoenix New Media Ltd is a media company providing premium content on an integrated platform across the internet, mobile and TV channels in China. The company organizes its operations into two main segments: Net advertising services and Paid services. It provides its content and services through three channels: ifeng.com channel, video channel, and mobile channel. The company also offers a wide range of paid services including mobile value-added services, games, and content sales. It generates the majority of its revenue from Net advertising services. Geographically, it derives all of its revenue from PRC.

Share on Social Networks: